People

Ashly Jordan
Ashly E. Jordan, PhD, MPH
NYS Office of Addiction Services and Supports (OASAS) - Director of Research and Program Evaluation
Education
PhD, Epidemiology, Graduate School of Public Health and Health Policy, City University of New York
MPH, Biostatistics and Epidemiology, School of Public Health, City University of New York
Research Interests
Societal (structural, social, and political) determinants of population health and inequities, infectious disease epidemiology, people who use drugs, hepatitis C virus, HIV, multi-level data analysis
BIO
Ashly Jordan is the Director of Research and Program Evaluation for the New York State Office of Addiction Services and Supports. She is an interdisciplinary epidemiologist with more than 15 years of applied research experience and public health practice focused on understanding how systems and interventions can improve health and social outcomes for people who use substances and who experience addiction. She has served as a consultant to the United Nations Office on Drugs and Crime. Dr. Jordan’s research has examined blood-borne and skin and soft tissue infections, tuberculosis, drug overdose, substance use epidemiology, and the impact of criminal legal involvement on substance use epidemiology and treatment trajectories. She has published extensively, including on prevention and care continua, Big Events theory, and novel metrics, and has served on study sections. Drawing on theory-based multi-level understanding of illness and health, and principles of health equity and social justice, Dr. Jordan’s research and public health practice has focused on the interplay between individual, social and structural factors on people who use substances.
Projects
Principal Investigator, Leveraging Regulatory Flexibility for Methadone Take-home Dosing to Improve Retention in Treatment for Opioid Use Disorder: A Stepped-wedge Randomized Trial to Facilitate Clinic Level Changes. Active
Principal Investigator, Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach. Active
Publications

Recent

Bachhuber MA, Cunningham CO, Jordan AE (2025).
Potential improvement in spatial accessibility of methadone treatment with integration into other outpatient substance use disorder treatment programs, New York City, 2024
PLoS One, 20 (2), e0317967. doi: 10.1371/journal.pone.0317967. PMCID: PMC11798429.

Choi S, Choi J, O'Grady M, Renteria D, Oueles C, Liebmann E, Lincourt P, Jordan AE, Neighbors CJ (2025).
Patient experiences in outpatient substance use disorder treatment: A qualitative study exploring both clinical and non-clinical contexts
Journal of Substance Use and Addiction Treatment, 169, 209581. doi: 10.1016/j.josat.2024.209581.

Bradley H, Nguyen T, Far SS, Jordan AE, Kamanu V, King R, Li LX, Luisi N, Mack S, Udo T, Rosenberg ES (2025).
Re: Estimation of opioid misuse prevalence in New York State counties, 2007-2018. A Bayesian spatio-temporal abundance model approach
American Journal of Epidemiology [Epub 2025 Jan 28]. doi: 10.1093/aje/kwae407.

Behrends CN, Trinidad AJ, Nolan ML, Dolatshahi J, Kingsepp A, Jordan AE, Welch AE, Harocopos A, Shaw LC, Green TC, Marshall BDL, Schackman BR (2025).
Expanded naloxone distribution by opioid overdose prevention programs to high-need populations and neighborhoods in New York City
Journal of Urban Health [Epub 2025 Jan 16]. doi: 10.1007/s11524-024-00951-y.

Bao Y, O'Grady MA, Hutchings K, Hu JC, Campbell K, Knopf E, Hussain S, Puryear L, Lincourt P, Jordan AE, Neighbors CJ (2025).
Payment and billing strategies to support methadone take-home medication: Perspectives of financial leaders of opioid treatment program organizations in New York State
Journal of Substance Use and Addiction Treatment, 168, 209547. doi: 10.1016/j.josat.2024.209547.


Notable

Jordan AE, Des Jarlais DC, Arasteh K, McKnight C, Nash D, Perlman DC (2015).
Incidence and prevalence of hepatitis C virus infection among persons who inject drugs in New York City: 2006-2013
Drug and Alcohol Dependence, 152, 194-200. doi: 10.1016/j.drugalcdep.2015.03.039. PMCID: PMC4458155.

Hagan H, Jordan AE, Neurer J, Cleland CM (2015).
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men
AIDS, 29 (17), 2335-2345. doi: 10.1097/QAD.0000000000000834. PMCID: PMC4640945.

Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC (2015).
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential
International Journal of Drug Policy, 26 (11), 1056-1063. doi: 10.1016/j.drugpo.2015.04.015. PMCID: PMC4581906.

Ashly Jordan's MyBibliography Profile